about
Individualized medicine enabled by genomics in Saudi ArabiaMolecular interaction of a kinase inhibitor midostaurin with anticancer drug targets, S100A8 and EGFR: transcriptional profiling and molecular docking study for kidney cancer therapeuticsGenomic structure and in vivo expression of the human organic anion transporter 1 (hOAT1) gene.Correlation of chromosomal imbalances by comparative genomic hybridization and expression of EGFR, PTEN, p53, and MIB-1 in diffuse gliomas.Transcriptomics profiling study of breast cancer from Kingdom of Saudi Arabia revealed altered expression of Adiponectin and Fatty Acid Binding Protein4: Is lipid metabolism associated with breast cancer?Effect of BRAF mutational status on expression profiles in conventional papillary thyroid carcinomasComparison of microarray expression profiles between follicular variant of papillary thyroid carcinomas and follicular adenomas of the thyroid.Polysomy 8 in three cases of homologous malignant mixed Müllerian tumors of the uterus.Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma ProgressionCyclin D1 as a therapeutic target of renal cell carcinoma- a combined transcriptomics, tissue microarray and molecular docking study from the Kingdom of Saudi Arabia.Associations of recurrent miscarriages with chromosomal abnormalities, thrombophilia allelic polymorphisms and/or consanguinity in Saudi Arabia.BRAF mutations in thyroid tumors from an ethnically diverse groupMyxoinflammatory fibroblastic sarcoma: investigations by comparative genomic hybridization of two cases and review of the literature.Low expression of leptin and its association with breast cancer: A transcriptomic study.Enhancement of Pathologist's Routine Practice: Reuse of DNA Extracted from Immunostained Formalin-fixed Paraffin-embedded (FFPE) Slides in Downstream Molecular Analysis of Cancer.Microarray expression profiling identifies genes, including cytokines, and biofunctions, as diapedesis, associated with a brain metastasis from a papillary thyroid carcinoma.Cytogenetic characterization of complex karyotypes in seven established melanoma cell lines by multiplex fluorescence in situ hybridization and DAPI banding.Molecular cytogenetic analysis of two primary squamous cell carcinomas of the lung using multicolor fluorescence in situ hybridization.Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma.Establishment and characterization of two distinct malignant mesothelioma cell lines with common clonal origin.Identification of a BAC clone overlapping the t(6p12.3) breakpoint in the cell line ESS-1 derived from an endometrial stromal sarcoma.Cytogenetic and DNA-fingerprint characterization of choriocarcinoma cell lines and a trophoblast/choriocarcinoma cell hybrid.Pleomorphism and drug resistant cancer stem cells are characteristic of aggressive primary meningioma cell lines.Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.Rectal adenocarcinoma with choriocarcinomatous differentiation: clinical and genetic aspects.Relationship between molecular variants and clinical manifestions in twelve glucose-6-phosphate dehydrogenase-deficient patients in Jordan.Comprehensive molecular biomarker identification in breast cancer brain metastases.Chromosomal micro-aberration in a Saudi family with Juvenile myoclonic epilepsy.Proangiogenic Effect of Metformin in Endothelial Cells Is via Upregulation of VEGFR1/2 and Their Signaling under Hyperglycemia-Hypoxia.Comparative genomic hybridization analysis on male breast cancer.Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.Impact of S100A8 expression on kidney cancer progression and molecular docking studies for kidney cancer therapeutics.Increased KIT signalling with up-regulation of cyclin D correlates to accelerated proliferation and shorter disease-free survival in gastrointestinal stromal tumours (GISTs) with KIT exon 11 deletions.Differential diagnosis of gastrointestinal leiomyoma versus gastrointestinal stromal tumor.Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.In situ characterization of stem cells-like biomarkers in meningiomas.Effects of Chemotherapy on the Cytogenetic Constitution of Wilms' TumorPleiotropic Effects of Metformin on CancerArray expression meta-analysis of cancer stem cell genes identifies upregulation of PODXL especially in DCC low expression meningiomas.
P50
Q26861059-1E573183-B49F-4279-B899-7F94FBCA7D4BQ28544659-6E56C90E-ECA4-43E9-A910-3C599678750EQ30913041-D175DA31-6723-4852-9D5B-7075615D2750Q34612948-4356E9F3-9D84-48C2-B9F4-511D7E5468D6Q35042566-A60AE005-B5D2-4235-B7C5-0C6452990DEBQ35042608-2DB987DB-53A9-4E16-9D2A-9CE17DB93333Q35042618-68C25A4F-C214-4604-AE42-4B5944875C0DQ35159986-8FC4F8D7-B3B8-40A1-9788-586BA0A35387Q35994740-7940A3E8-6B43-47BB-9110-3DCE6022EF7DQ36170317-DB816C1D-2125-4818-B733-2FF0739B7012Q36170357-3DADF225-4F3B-434C-8E34-BFA28A63DD61Q36209491-5BA0A33A-5C42-4EF5-A333-C9720493A3EDQ36908495-2CABE3F2-C4CF-4E57-AD71-A7E469E057B3Q36983780-F972B546-70AF-41F1-BB5A-30D843D4CA51Q37350983-9FF72631-7A40-4619-A308-ABC307B47B3EQ37382508-299E0E69-6655-4FEB-B9C4-CA9865539942Q38489612-E89534E2-EB0D-48A8-A724-5F5A7A367480Q38492450-81E38036-0334-4EAF-A890-2FC093A64DBEQ39999335-4833D502-F92F-4BE5-95DC-046797651538Q40118684-22189AE6-FD31-4219-BC7A-F51687339ED0Q40622618-6B4C5F10-244E-47C2-9D6C-650AF4D15EFAQ40909133-20BF7BC8-B577-4993-9D90-82D3062B02A1Q41085366-AD958C7F-F791-4A71-BC94-95B8554FB897Q42256102-0A92B848-D0C8-4E62-A1A2-96423BB373BBQ45237074-18D922E7-D6AB-4847-A6A2-8C3073CE298EQ46653029-744DD0B3-3FAB-4D45-AC5B-AC294BA32BEAQ47098306-6A2806F5-276F-4B8C-BF0D-5032B05D442EQ47682118-44B8D5A0-3411-47BB-852D-38A601DC44BEQ48207705-164BF056-B5FC-48A6-A778-D9A48D0D90DDQ51828262-5268FC71-6CED-4DF4-B37B-1679CD545F10Q52648265-CC735CD4-BFED-4D5E-B262-71A1C9C11A8BQ52649049-984F9E1E-2C4F-498B-844B-979CE658C9EAQ53458117-E4E1A339-231B-44FA-BA6B-476076558E6AQ53585563-7630999A-1806-4884-8157-86C8E7AEA669Q53657096-513A7EA8-4815-4184-8D04-C5F034171282Q54540636-D5733ED8-5C7C-4C1F-A2B6-A3823E492978Q54983777-D6FF7E80-3DFD-4A8F-B7BC-D03FAA09F6A2Q57339680-0F54F2C1-1D47-4D76-961E-D4BA49FFEAC6Q59138314-57CF0AA2-C0CF-4123-B124-022469B202C9Q64945719-05D24326-5507-4A98-9C15-8D9B744B3E04
P50
description
onderzoeker
@nl
researcher ORCID id 0000-0002-4907-3222
@en
name
Hans-Juergen Schulten
@ast
Hans-Juergen Schulten
@en
Hans-Juergen Schulten
@es
Hans-Juergen Schulten
@nl
type
label
Hans-Juergen Schulten
@ast
Hans-Juergen Schulten
@en
Hans-Juergen Schulten
@es
Hans-Juergen Schulten
@nl
prefLabel
Hans-Juergen Schulten
@ast
Hans-Juergen Schulten
@en
Hans-Juergen Schulten
@es
Hans-Juergen Schulten
@nl
P106
P31
P496
0000-0002-4907-3222